#United States #North Chicago #Patient Care #Allergan Aesthetics #AA Signature

Allergan Aesthetics Unveils New AA Signature Program at IMCAS 2025

In a compelling move that highlights the increasing demand for personalized aesthetic solutions, Allergan Aesthetics, a brand under AbbVie, has launched the AA Signature program at the IMCAS World Congress in 2025. This innovative program represents a progressive approach to treatment planning, focusing heavily on maximizing patient outcomes and satisfaction.

Addressing Patient Needs

Data indicates that approximately 80% of patients are more likely to undergo treatment after an immersive consultation. The AA Signature program leans into this trend by combining top-tier products to create unique, customized aesthetic solutions. By utilizing Allergan Aesthetics’ extensive product range, healthcare providers (HCPs) can now cater to various patient needs and preferences.

Key features of the AA Signature program were showcased at the international congress, accentuating how this strategy addresses critical aspects that often come up in clinical settings. Among these are:

• - Lift: Patients are increasingly seeking added lift, structure, and firmness in their skin. Research shows that 90% of individuals are interested in holistic plans targeting multiple facial areas.
• - Definition: Improved facial angles and enhanced lower face definition are priorities for over one-third of patients.
• - Skin Quality: A significant 94% of respondents wish to enhance their facial skin quality, highlighting the demand for smoother and more hydrated skin.

Multimodal Treatment Excellence

Extensive research underpins the AA Signature philosophy, revealing that clinical practices offering comprehensive treatment plans—addressing various facial areas—experience a 68% increase in patient retention when compared to those focusing solely on single areas. This holistic approach is set to empower HCPs, enabling them to deploy tailored treatment plans that enhance patient satisfaction and loyalty.

The AA Signature program promises to evolve as Allergan Aesthetics expands its product offerings. The program will introduce more novel looks and treatment strategies worldwide, adapting to emerging trends while connecting healthcare providers with cutting-edge tools and education necessary to meet the diverse needs of an increasingly sophisticated aesthetic marketplace.

A Commitment to Educating HCPs

Mark Wilson, the Senior Vice President and Head of International Commercial at Allergan Aesthetics, articulated the program's focus. He stated, "The AA Signature program directly addresses the growing inclination for a holistic treatment approach. It empowers HCPs by providing access to expert insights, comprehensive training programs, and unmatched business support—all designed to align with patients' aesthetic aspirations."

The launch of the AA Signature program not only reflects Allergan Aesthetics’ commitment to the aesthetic industry but also underscores the importance of educating providers so they can confidently discuss and implement treatment plans that cater to their patients’ desires.

Next Steps for HCPs

HCPs interested in the AA Signature program are encouraged to reach out to their local Allergan representatives to explore availability in their respective countries as the program rolls out globally.

About AbbVie

AbbVie strives to discover and develop groundbreaking solutions for serious health challenges affecting lives across the globe. With a focus on vital therapeutic areas such as immunology, oncology, neuroscience, and eye care, AbbVie continues to innovate within Allergan Aesthetics, fostering advances that empower both clinicians and patients alike.

For more updates, visit AbbVie and Allergan Aesthetics.